Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21
Authors:
Open Access
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 17, 306-319
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81572960, 81773231)
This publication has 42 references indexed in Scilit:
- High DNA Methyltransferase DNMT3B Levels: A Poor Prognostic Marker in Acute Myeloid LeukemiaPLOS ONE, 2012
- p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAsNature Cell Biology, 2011
- DNA methyltransferase DNMT3b protein overexpression as a prognostic factor in patients with diffuse large B‐cell lymphomasCancer Science, 2010
- DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal CancerClinical Cancer Research, 2009
- p21 in cancer: intricate networks and multiple activitiesNature Reviews Cancer, 2009
- DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell linesMolecular Cancer, 2008
- Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencingGenes & Development, 2007
- p21Waf1/Cip1 plays a critical role in modulating senescence through changes of DNA methylationJournal of Cellular Biochemistry, 2006
- 5-Aza-2′-deoxycytidine Activates the p53/p21Waf1/Cip1 Pathway to Inhibit Cell ProliferationJournal of Biological Chemistry, 2004
- The role of p53 in determining sensitivity to radiotherapyNature Reviews Cancer, 2003